跳至主要内容
临床试验/2025-524744-36-00
2025-524744-36-00招募中2 期

DOXYCYCLINE PENETRATION INTO BONE AND JOINT.

Centre Hospitalier Universitaire De Caen Normandie1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2026年6月1日最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
招募中
入组人数
30
试验地点
1
主要终点
To measure doxycycline penetration in cancellous bone using the cancellous bone concentration/plasmatic concentration ratio

研究概览

简要总结

The objective of this study is to provide robust data on bone penetration of the doxycycline in non-infected patient. The primary objective is to determine the penetration of doxycycline in cancellous bone.

入排标准

年龄范围
18 years 至 65+ years(18-64 Years, 65+ Years)
接受健康志愿者

入选标准

  • Age between 18 and 80 years old.
  • Scheduled for elective surgery for hip replacement due to coxarthrosis
  • Signed informed consent
  • Patients eligible for French social insurance
  • Participants able to fully understand the study and who accept its requirements and constraints

排除标准

  • Patients with contraindications to doxycycline ( hypersensitivity to the active substance or to any of the excipients (particularly as generic formulations are authorized in the study and excipients may therefore differ), hypersensitivity to tetracycline-class antibiotics, co-administration of retinoids, or vitamin A supplementation exceeding 10,000 IU/day, due to the risk of intracranial hypertension and intestinal obstruction).
  • Patient with a contraindication to surgical procedure
  • history of osteoarticular infection related to hip prosthesis surgery
  • Patient who has received antibiotics within one month prior to the procedure
  • Patient who did not take Doxycycline as planned in the protocol.
  • Patient being a relative of the investigator or any member of the team directly involved in the study, including assistant physicians, pharmacists, nurses, and coordinators.
  • malabsorption syndrome or conditions likely to impair antibiotic absorption (sleevs, colectomy, gastrointestinal antacids (magnesium, aluminum, or calcium salts, oxides, or hydroxides) and oral iron salts……)
  • Malnutrition patient (BMI < 21 kg/m2) or with serum albumin < 30g/L
  • Kidney failure with GFR < 60 mL/min/1,73m2
  • Patients unable to take oral doxycycline
  • Pregnant or breastfeeding women
  • Women of childbearing age without effective contraception : childbearing age means non menopausal women. Effective contraception includes taking a contraceptive pill or using an Intra Uterine Device.
  • Patients under guardianship, curatorship, legal protection or conservatorship
  • Patient with an infection at the time of surgical management

结局指标

主要结局

To measure doxycycline penetration in cancellous bone using the cancellous bone concentration/plasmatic concentration ratio

To measure doxycycline penetration in cancellous bone using the cancellous bone concentration/plasmatic concentration ratio

次要结局

  • To mesure the concentration of Doxycycline in cortical bone using the cortical bone concentration/plasmatic concentration ratio
  • To measure the concentration of Doxycycline in synovial fluid using the synovial fluid concentration/plasmatic concentration ratio

研究者

申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Investigateur coordinateur

Scientific

Centre Hospitalier Universitaire De Caen Normandie

研究点 (1)

Loading locations...

相似试验